Market Challenges And Opportunities

Ventricular Drainage Sets Market Dynamics

High incidence of intraventricular hemorrhage associated with premature baby birth is expected to drive the ventricular drainage sets market growth over the forecast period. According to study published in Child’s Nervous System, 2016, intraventricular hemorrhage is commonly observed in 15%-20% of babies born before 32 weeks of gestation.

Furthermore, rising incidence of neurological disorders is leading to increasing demand for ventricular drainage sets, in turn propelling the ventricular drainage sets market growth. According to American Neurological Association, 2017, annual incidence of traumatic brain injury in the U.S. ranges from 1.4 million to 1.7 million. Moreover, the rate of traumatic injury increases with increasing age due to weakened neurological response.

Increasing road accidents is also expected to propel growth of the ventricular drainage set market. In countries such as India and China, road accidents accounts for high rate of traumatic injuries, in turn leading to increasing demand for ventricular drainage sets. For instance, according to Government of India, in 2016, injuries, disabilities, and deaths caused by road accidents accounted for around 494,624 injuries, with 1,317 accidents per day.

Moreover, according to Global Burden of Disease report, road injuries is among the top 20 leading cause of mortality, globally. In addition to this, according to the World Health Organization (WHO), road injuries are expected to become 7^th leading cause of death by 2030, if road traffic crashes are not controlled.

New product approvals are further contributing towards the ventricular drainage sets market growth. For instance, in 2017, Arkis BioScience, an innovator and provider of minimally invasive surgical instrumentation and catheters for surgeries, received FDA clearance for its product, CerebroFlo, a new external ventricular catheter.

However, complications associated with the use of ventricular drainage are expected to be a major restraining factor for the ventricular drainage sets market growth. The two most common complications associated with external ventricular drain are infection and hemorrhage. Moreover, lack of skilled professionals for neurological surgeries add on the risk of infection and hemorrhage.

Major companies operating in the global ventricular drainage sets market include Integra LifeSciences Corporation, Medtronic plc, Fuji Systems Corporation, Moller Medical GmbH, Sophysa, Dispomedica, and Spiegelberg GmbH & Co. KG.